Citadel Advisors
FCSC

Citadel Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Citadel Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,525
Closed -$26K – 10248
2019
Q1 		$26K Sell
13,525
-16,401
-55% -$32.6K ﹤0.01% 9020
2018
Q4 		$45K Buy
+29,926
New +$59.9K ﹤0.01% 8519
2016
Q2 		– Sell
-2,028
Closed -$76K – 7693
2016
Q1 		$76K Buy
+2,028
New +$81K ﹤0.01% 6137

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Citadel Advisors's FCSC Position: Q2 2019 in Review

Citadel Advisors sold out of Fibrocell Science Inc. (FCSC) in Q2 2019, closing a stake of 13,525 shares — an estimated $26K sold.

Citadel Advisors first reported a position in FCSC in Q1 2016 and held it in 3 quarters. The position peaked at $76K in Q1 2016. 20 funds tracked by Wall St. Rank hold FCSC as of Q2 2019.

  • Citadel Advisors reported no remaining Fibrocell Science Inc. position as of Q2 2019 after selling out during the quarter.
  • Citadel Advisors sold 13,525 Fibrocell Science Inc. shares in Q2 2019, an estimated $26K.
  • Citadel Advisors first reported a position in Fibrocell Science Inc. in Q1 2016 and held it in 3 quarters.
  • Citadel Advisors's Fibrocell Science Inc. position peaked at $76K in Q1 2016.
  • 20 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2019.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.